SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-056458
Filing Date
2019-11-13
Accepted
2019-11-13 17:56:42
Documents
1
Period of Report
2019-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1511
  Complete submission text file 0001209191-19-056458.txt   3045
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INOVIO PHARMACEUTICALS, INC. 660 W. GERMANTOWN PIKE, SUITE 110 PLYMOUTH MEETING PA 19462
Business Address
Miller Ann Calby (Reporting) CIK: 0001771423 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35703 | Film No.: 191215591